| Product Code: ETC10402159 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel`s import shipments of recombinant hormones continued to showcase a high level of market concentration, with top exporting countries including Switzerland, USA, Germany, China, and Belgium. The market saw a significant decline in CAGR from 2020 to 2024 at -13.88%, but there was a positive growth rate of 8.63% from 2023 to 2024. This data suggests a dynamic landscape for recombinant hormone imports in Israel, with potential opportunities for further market expansion and diversification in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Recombinant Hormone Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Recombinant Hormone Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Recombinant Hormone Market - Industry Life Cycle |
3.4 Israel Recombinant Hormone Market - Porter's Five Forces |
3.5 Israel Recombinant Hormone Market Revenues & Volume Share, By Hormone Type, 2021 & 2031F |
3.6 Israel Recombinant Hormone Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Recombinant Hormone Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Israel Recombinant Hormone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hormone-related disorders in Israel |
4.2.2 Growing awareness and acceptance of recombinant hormone therapies |
4.2.3 Technological advancements in recombinant hormone production and delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of recombinant hormone products |
4.3.2 High cost associated with recombinant hormone therapies |
4.3.3 Limited availability of recombinant hormone products in certain regions of Israel |
5 Israel Recombinant Hormone Market Trends |
6 Israel Recombinant Hormone Market, By Types |
6.1 Israel Recombinant Hormone Market, By Hormone Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Recombinant Hormone Market Revenues & Volume, By Hormone Type, 2021 - 2031F |
6.1.3 Israel Recombinant Hormone Market Revenues & Volume, By Insulin, 2021 - 2031F |
6.1.4 Israel Recombinant Hormone Market Revenues & Volume, By Growth Hormone, 2021 - 2031F |
6.1.5 Israel Recombinant Hormone Market Revenues & Volume, By Erythropoietin, 2021 - 2031F |
6.2 Israel Recombinant Hormone Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Recombinant Hormone Market Revenues & Volume, By Diabetes Management, 2021 - 2031F |
6.2.3 Israel Recombinant Hormone Market Revenues & Volume, By Growth Disorders, 2021 - 2031F |
6.2.4 Israel Recombinant Hormone Market Revenues & Volume, By Anemia Treatment, 2021 - 2031F |
6.3 Israel Recombinant Hormone Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Israel Recombinant Hormone Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.3 Israel Recombinant Hormone Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.4 Israel Recombinant Hormone Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
7 Israel Recombinant Hormone Market Import-Export Trade Statistics |
7.1 Israel Recombinant Hormone Market Export to Major Countries |
7.2 Israel Recombinant Hormone Market Imports from Major Countries |
8 Israel Recombinant Hormone Market Key Performance Indicators |
8.1 Average time to market approval for new recombinant hormone products in Israel |
8.2 Patient adherence rates to recombinant hormone therapies |
8.3 Number of clinical trials focusing on new recombinant hormone treatments in Israel |
9 Israel Recombinant Hormone Market - Opportunity Assessment |
9.1 Israel Recombinant Hormone Market Opportunity Assessment, By Hormone Type, 2021 & 2031F |
9.2 Israel Recombinant Hormone Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Recombinant Hormone Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Israel Recombinant Hormone Market - Competitive Landscape |
10.1 Israel Recombinant Hormone Market Revenue Share, By Companies, 2024 |
10.2 Israel Recombinant Hormone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here